Early evaluation of targeted drugs using dynamic contrast-enhanced ultrasonography for personalized medicine.
about
The antiangiogenic effects of a vascular endothelial growth factor decoy receptor can be monitored in vivo using contrast-enhanced ultrasound imaging.Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab.Molecular Imaging to Predict Response to Targeted Therapies in Renal Cell Carcinoma.How to perform Contrast-Enhanced Ultrasound (CEUS).Sorafenib plus dacarbazine in solid tumors: a phase I study with dynamic contrast-enhanced ultrasonography and genomic analysis of sequential tumor biopsy samples.
P2860
Early evaluation of targeted drugs using dynamic contrast-enhanced ultrasonography for personalized medicine.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Early evaluation of targeted d ...... phy for personalized medicine.
@en
Early evaluation of targeted d ...... phy for personalized medicine.
@nl
type
label
Early evaluation of targeted d ...... phy for personalized medicine.
@en
Early evaluation of targeted d ...... phy for personalized medicine.
@nl
prefLabel
Early evaluation of targeted d ...... phy for personalized medicine.
@en
Early evaluation of targeted d ...... phy for personalized medicine.
@nl
P2093
P2860
P356
P1433
P1476
Early evaluation of targeted d ...... phy for personalized medicine.
@en
P2093
David Cosgrove
Jean-Pierre Armand
Nathalie Lassau
P2860
P304
P356
10.2217/FON.12.114
P407
P577
2012-10-01T00:00:00Z